ETF Holdings Breakdown of SANA

Stock NameSana Biotechnology Inc
TickerSANA(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS7995661045

News associated with SANA

JMP Securities Reaffirms Market Outperform Rating for Sana Biotechnology (NASDAQ:SANA)
Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “market outperform” rating reiterated by analysts at JMP Securities in a research note issued on Tuesday,Benzinga reports. They currently have a $5.00 price target on the stock. JMP Securities’ target price indicates a potential upside of 72.41% from the company’s previous close. Several other brokerages […] - 2025-06-26 06:13:02
Hsbc Holdings PLC Buys 19,084 Shares of Sana Biotechnology, Inc. (NASDAQ:SANA)
Hsbc Holdings PLC raised its stake in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 140.1% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 32,704 shares of the company’s stock after purchasing an additional 19,084 shares during the period. Hsbc Holdings […] - 2025-05-13 08:06:58
Legal & General Group Plc Has $263,000 Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)
Legal & General Group Plc reduced its holdings in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The fund owned 161,177 shares of the company’s stock after selling 6,823 shares during the period. Legal & General Group Plc’s holdings in Sana Biotechnology were worth $263,000 at the end […] - 2025-05-01 07:57:03
Sana Biotechnology, Inc. (NASDAQ:SANA) Stake Raised by ExodusPoint Capital Management LP
ExodusPoint Capital Management LP grew its holdings in shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 174.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 272,908 shares of the company’s stock after purchasing an additional 173,442 shares during […] - 2025-04-13 08:33:23
Teacher Retirement System of Texas Has $60,000 Position in Sana Biotechnology, Inc. (NASDAQ:SANA)
Teacher Retirement System of Texas boosted its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 20.3% in the fourth quarter, HoldingsChannel reports. The firm owned 36,797 shares of the company’s stock after buying an additional 6,209 shares during the period. Teacher Retirement System of Texas’ holdings in Sana Biotechnology were worth $60,000 as […] - 2025-04-03 07:16:48
Wednesday's ETF Movers: XBI, PICK
In trading on Wednesday, the SPDR S&P Biotech ETF is outperforming other ETFs, up about 2.7% on the day. Components of that ETF showing particular strength include shares of Scilex Holding, up about 28.8% and shares of Sana Biotechnology, up about 16% on the day. And under - 2025-04-02 16:28:39
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by Corient Private Wealth LLC
Corient Private Wealth LLC increased its position in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 161.7% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 1,182,699 shares of the company’s stock after purchasing an additional 730,699 shares during the period. Corient Private Wealth LLC owned 0.53% […] - 2025-03-25 07:53:07
HC Wainwright Reiterates Buy Rating for Sana Biotechnology (NASDAQ:SANA)
Sana Biotechnology (NASDAQ:SANA – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at HC Wainwright in a report released on Tuesday,Benzinga reports. They presently have a $11.00 price target on the stock. HC Wainwright’s target price indicates a potential upside of 370.09% from the company’s previous close. Several other brokerages also […] - 2025-03-20 06:28:49
Sana Biotechnology (NASDAQ:SANA) Upgraded at Citizens Jmp
Citizens Jmp upgraded shares of Sana Biotechnology (NASDAQ:SANA – Free Report) from a market perform rating to an outperform rating in a report issued on Tuesday, Marketbeat reports. They currently have $5.00 price target on the stock. A number of other equities research analysts have also recently issued reports on SANA. HC Wainwright boosted their […] - 2025-03-19 06:47:01
Sana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of “Moderate Buy” by Brokerages
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA – Get Free Report) have been given a consensus rating of “Moderate Buy” by the seven ratings firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The […] - 2025-03-19 06:06:50
Sana Biotechnology, Inc. (NASDAQ:SANA) Shares Acquired by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. increased its stake in Sana Biotechnology, Inc. (NASDAQ:SANA – Free Report) by 10.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 47,341 shares of the company’s stock after buying an additional 4,554 shares during the quarter. China […] - 2025-02-04 08:53:05

SANA institutional holdings

The following institutional investment holdings of SANA have been identified

Date ETF ISIN/Name Num Shares Book value
2025-05-29 IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc)) 95,220USD 216,149 0.9%
2025-05-29 IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc) 33,426USD 75,877 0.9%
2025-06-26 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 115,762USD 332,237
2025-06-26 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 115,762USD 332,237
2025-05-29 IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc)) 1,666USD 3,782 0.9%
Total =361,836 USD 960,282
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.